MedPath

The effect of Saffron on motor and depressive symptoms in patients with Parkinson's disease

Phase 2
Conditions
Severity of depressive and motor symptoms.
Parkinson's disease
Registration Number
IRCT20090117001556N145
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Age 30-75
Diagnosis for Parkinson's disease by Neurologist
Diagnosis of depression, mild to moderate according to HAM-D

Exclusion Criteria

Age outside the range of 30-75 years
Diagnosis or history of other neurological diseases such as epilepsy and Alzheimer's disease
Diagnosis or history of vascular disorders, dementia and stroke
Diagnosis or history of other psychiatric disorders such as bipolar disorder
Addiction
Antipsychotic use in the past year
Diagnosis of central nervous system infections such as meningitis during the study
Use of Linezolid at the beginning of the study, or during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of depressive and motor symptoms. Timepoint: Weeks 0 - 4 - 8. Method of measurement: By Hamiltion Depression Rating Scale & MDS-UPDRS III.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath